Oxis Turbuhaler (Formoterol Fumarate Dihydrate)

Formoterol fumarate dihydrate, the active ingredient in Oxis Turbuhaler, is a long‑acting β2‑adrenergic agonist presented as a dry‑powder inhaler for inhalation use. It provides bronchodilation for patients with asthma and chronic obstructive pulmonary disease. GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Formoterol fumarate dihydrate is used in the management of chronic airway diseases, acting on the bronchial smooth muscle to improve airflow.

- Asthma: improves lung function and reduces the frequency of symptoms. - Chronic obstructive pulmonary disease (COPD): provides sustained bronchodilation and helps reduce exacerbations. - Exercise‑induced bronchoconstriction: prevents narrowing of the airways during physical activity.

Formoterol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Tremor: mild shaking of the hands. - Headache: occasional mild to moderate headache. - Throat irritation: sensation of dryness or irritation in the throat. - Cough: transient coughing after inhalation. - Palpitations: awareness of heart beating faster than usual. - Nervousness: feeling of unease or jittery sensation.

Serious or Rare Side Effects: - Paradoxical bronchospasm: sudden worsening of breathing. - Cardiac arrhythmia: irregular heart rhythm that may require medical attention. - Hypokalemia: low blood potassium levels. - Severe allergic reactions: rash, itching, swelling, or difficulty breathing. - Hyperglycemia: elevated blood glucose levels. - Pulmonary d   

Formoterol should be taken 

-    g   t \